CAS 14446-47-0: Thiazolidine, hydrochloride

Thiazolidine HCl is a heterocycle that inhibits protein synthesis by binding to the receptor site of the ribosome. The drug has been shown to have anti-inflammatory and antioxidant effects in vitro, and it has been shown to have an inhibitory effect on oxidative damage and nitric oxide production in vivo, which may be due to its ability to scavenge reactive oxygen species. Thiazolidine HCl has also been shown to have neuroprotective properties, which may be due to its ability to reduce glutaminyl cyclase activity. Thiazolidine HCl has been proposed as a treatment for autoimmune diseases such as rheumatoid arthritis and psoriasis. It has also been shown that thiazolidine HCl can inhibit tumor growth in cancer cells.

Thiazolidine hydrochloride